PTC Therapeutics (PTCT)

• Market cap: $4.07B
• 1 day: -1.60%
• 5 days: -0.32%
• 1 month: 6.20%
• 3 months: 13.76%
• 6 months: 55.19%
• Year to date: 14.97%
• 1 year: 71.32%
• 5 years: 20.05%
• 10 years: -28.01%
• Sector: Healthcare
• Industry: Pharmaceutical Preparations

Fund manager confidence

Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)

229% more first-time investments, than exits

New positions opened: 56 | Existing positions closed: 17

19% more capital invested

Capital invested by funds: $2.95B [Q3] → $3.51B (+$562M) [Q4]

18% more funds holding

Funds holding: 201 [Q3] → 237 (+36) [Q4]

1% more repeat investments, than reductions

Existing positions increased: 77 | Existing positions reduced: 76

2.7% less ownership

Funds ownership: 103.48% [Q3] → 100.78% (-2.7%) [Q4]

25% less funds holding in top 10

Funds holding in top 10: 4 [Q3] → 3 (-1) [Q4]

62% less call options, than puts

Call options by funds: $10.6M | Put options by funds: $28.2M

Research analyst outlook

7 Wall Street Analysts provided 1 year price targets over the past 3 months

• Low target: $45 15% downside
• Avg. target: $68 28% upside
• High target: $113 114% upside

7 analyst ratings

• positive: 4 57%
• neutral: 2 29%
• negative: 1 14%

B of A Securities Tazeen Ahmad 29% 1-year accuracy 10 / 34 met price target	4% upside $55	Neutral Upgraded	11 Mar 2025
Scotiabank Louise Chen 37% 1-year accuracy 52 / 142 met price target	4% upside $55	Sector Perform Initiated	7 Mar 2025
Morgan Stanley Jeffrey Hung 29% 1-year accuracy 8 / 28 met price target	33% upside $70	Overweight Assumed	7 Mar 2025
JP Morgan Eric Joseph 46% 1-year accuracy 12 / 26 met price target	36% upside $72	Overweight Maintained	28 Feb 2025
RBC Capital Brian Abrahams 15% 1-year accuracy 11 / 71 met price target	19% upside $63	Outperform Maintained	18 Feb 2025